(Q44095666)

29 November 2017

Pharmacokinetic interactions between warfarin and kangen-karyu, a Chinese traditional herbal medicine, and their synergistic action (English)

1 reference

29 November 2017

0 references

1 reference

1 reference

Toshiaki Makino

1

1 reference

29 November 2017

Hannosuke Wakushima

2

1 reference

29 November 2017

Takuya Okamoto

3

1 reference

29 November 2017

Yasuhiro Okukubo

4

1 reference

29 November 2017

Yoshiharu Deguchi

5

1 reference

29 November 2017

Yoshihiro Kano

6

1 reference

29 November 2017

1 September 2002

1 reference

Journal of Ethnopharmacology

29 November 2017

1 reference

29 November 2017

82

1 reference

29 November 2017

1

1 reference

29 November 2017

35-40

1 reference

Why patients use alternative medicine: results of a national study

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Complementary and alternative medicine use among elderly persons: one-year analysis of a Blue Shield Medicare supplement

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Interaction between warfarin and danshen (Salvia miltiorrhiza)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Fish oil feeding lowers thromboxane- and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

A taste of Chinese medicine!

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Effects of Kangen-karyu on coagulation system and platelet aggregation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Kangenkaryu prevents the decrease of cholinergic markers following the nucleus basalis magnocellularis lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Warfarin interactions with Chinese traditional medicines: danshen and methyl salicylate medicated oil

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Worldwide prevention of cancer and other chronic diseases based on knowledge of mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Statistical moments in pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

Chinese herbs and warfarin potentiation by 'Danshen'

1 reference

https://api.crossref.org/works/10.1016%2FS0378-8741%2802%2900175-7

7 January 2021

10.1016/S0378-8741(02)00175-7

Identifiers

DOI

1 reference

29 November 2017

1 reference